Abstract:Two important features are required for promising radiosensitizers: one is selective tumor cell targeting to enhance the therapeutic outcome via lethal DNA damage and the other is rapid clearance to enable excellent biocompatibility for potential clinical application. Herein, ultrasmall gold nanoparticles (Au NPs) with diameter smaller than 5 nm were prepared and covered with a multifunctional peptide to endow them with selective tumor cell uptake capability. Combined with X-ray irradiation, the responsive Au NPs demonstrated superior radio-sensitizing toxicity and rapid renal clearance in vivo. Methods: A responsive peptide (Tat-R-EK) consists of three build blocks were used: a cell and even nuclear penetrating block derived from human immunodeficiency virus-1 transactivator of transcription protein (Tat), an cathepsin B cleavable linker, and a zwitterionic antifouling block. Ultrasmall Au NPs were prepared and then covered by the peptide via the Au-S bonds between gold and thiol groups from cysteine. The morphology, colloidal stability and the responsiveness of obtained Au@Tat-R-EK NPs were studied using transmittance electron microscopy and dynamic laser scattering. The selective cancer cell uptake and accumulation of Au@Tat-R-EK NPs in cancer tissue were studied via ICP-MS in vitro and in vivo, respectively. The cytotoxicity of Au@Tat-R-EK NPs on HepG2 cancer cells was evaluated in terms of cell viability, DNA damage, intracellular reactive oxygen species generation, and apoptosis analysis. Finally, the biocompatibility and tumor destruction ability against orthotopic LM3 liver cancers were verified in vivo. Results: Multifunctional peptide modified ultrasmall Au NPs were successfully prepared. The Au NPs exhibited enough colloidal stability and cathepsin B-responsive surface change, leading to selectively uptake by cancer cells in vitro and accumulation to tumor sites in vivo. Combined with X-ray irradiation, the responsive Au NPs demonstrated superior radio-sensitizing cytotoxicity in vitro and therapeutic outcome on mouse liver cancer in vivo. The ultrasmall size enables rapid clearance of the Au NPs, guarantees the biocompatibility in vivo for potential clinical applications. Conclusion: Some obstacles faced by the Au NPs-based radiotherapy, such as short circulation half-life, non-specific distribution, slow clearance and low radio-sensitizing effect, were effective solved through rational design of the smart nanomedicine. This work provides new insight in designing tumor microenvironment-responsive nanomedicine in cancer radiotherapy.

Emerging Plasmonic Nanoparticles and Their Assemblies for Cancer Radiotherapy

Plasmonic nanomaterials: A versatile phototheranostic platform of cancers

Emerging Nanoradiosensitizers and Nanoradioprotectants for Enhanced Cancer Theranostics

Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy

Plasmonic AuPt@CuS Heterostructure with Enhanced Synergistic Efficacy for Radiophotothermal Therapy

Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy

Harnessing the Collective Properties of Nanoparticle Ensembles for Cancer Theranostics

Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy.

A Hollow‐Structured CuS@Cu2S@Au Nanohybrid: Synergistically Enhanced Photothermal Efficiency and Photoswitchable Targeting Effect for Cancer Theranostics

Catalytic Radiosensitization: Insights from Materials Physicochemistry

Multifunctional High-Z Nanoradiosensitizers for Multimodal Synergistic Cancer Therapy.

Tailoring Bi-based Nanoparticles for Enhanced Radiosensitivity in Cancer Therapy

Metal-Based Hybrid Nanoparticles As Radiosensitizers in Cancer Therapy

Application of nanomedicine in radiotherapy sensitization

Plasmonic Nanoassemblies for Surface-Enhanced Raman Scattering-Based Biodetection and Biomedical Theranostics

Enhancing X‐Ray Sensitization with Multifunctional Nanoparticles

Advances of Nanomedicine in Radiotherapy

Tailoring Bismuth-Based Nanoparticles for Enhanced Radiosensitivity in Cancer Therapy

Multifunctional high-<i>Z</i> nanoradiosensitizers for multimodal synergistic cancer therapy

Enhancement of Radiosensitization by Metal-Based Nanoparticles in Cancer Radiation Therapy

Self-Assembled Nanomaterials for Enhanced Phototherapy of Cancer.